Zhaoke Ophthalmology Limited (HKG:6622)
Hong Kong · Delayed Price · Currency is HKD 2.500
+0.015 (0.60%)
Sep 18, 2026, 3:45 PM HKT
Zhaoke Ophthalmology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 35 | 31.97 | 69.32 | 18.75 | - | - | |
Revenue Growth | -1.01% | -53.88% | 269.73% | - | - | - |
Cost of Revenue | 17.67 | 15.92 | 17.53 | 4.5 | - | - |
Gross Profit | 17.33 | 16.05 | 51.8 | 14.25 | - | - |
Selling, General & Admin | 121.98 | 117.92 | 134.28 | 136.29 | 116.06 | 178.82 |
Research & Development | 164.33 | 171.62 | 203.7 | 333.05 | 296.43 | 220.06 |
Other Operating Expenses | -0.5 | -0.5 | 2.94 | -1.26 | -0.15 | -0.01 |
Operating Expenses | 285.81 | 289.05 | 340.92 | 468.09 | 412.34 | 398.87 |
Operating Income | -268.47 | -273 | -289.12 | -453.84 | -412.34 | -398.87 |
Interest Expense | -9.72 | -9.08 | -9.5 | -7.92 | -3.14 | -1.95 |
Interest & Investment Income | 44.37 | 44.37 | 75.23 | 77.4 | 30.42 | 5.04 |
Currency Exchange Gain (Loss) | 28.44 | 28.44 | -14.71 | -3.65 | -29.73 | 13.41 |
Other Non Operating Income (Expenses) | -9.86 | - | - | - | - | -1,763 |
EBT Excluding Unusual Items | -215.24 | -209.27 | -238.11 | -388.01 | -414.8 | -2,146 |
Asset Writedown | - | - | -10.81 | - | - | - |
Other Unusual Items | 0.29 | 0.29 | 11.42 | 3.52 | 7.48 | 16.09 |
Pretax Income | -214.95 | -208.98 | -237.49 | -384.49 | -407.32 | -2,130 |
Income Tax Expense | - | - | - | 0.55 | - | - |
Net Income | -214.95 | -208.98 | -237.49 | -385.04 | -407.32 | -2,130 |
Net Income to Common | -214.95 | -208.98 | -237.49 | -385.04 | -407.32 | -2,130 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 548 | 547 | 546 | 544 | 542 | 412 |
Shares Outstanding (Diluted) | 548 | 547 | 546 | 544 | 542 | 412 |
Shares Change | 0.36% | 0.15% | 0.41% | 0.32% | 31.47% | 173.12% |
EPS (Basic) | -0.39 | -0.38 | -0.43 | -0.71 | -0.75 | -5.16 |
EPS (Diluted) | -0.39 | -0.38 | -0.43 | -0.71 | -0.75 | -5.16 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -264.57 | -263.82 | -360.13 | -409.7 | -310.67 |
Free Cash Flow Per Share | - | -0.48 | -0.48 | -0.66 | -0.76 | -0.75 |
Gross Margin | 49.53% | 50.21% | 74.72% | 75.98% | - | - |
Operating Margin | -767.08% | -853.81% | -417.06% | -2420.47% | - | - |
Profit Margin | -614.17% | -653.60% | -342.58% | -2053.54% | - | - |
Free Cash Flow Margin | - | -827.45% | -380.56% | -1920.70% | - | - |
EBITDA | -232.8 | -238.36 | -253.22 | -420.16 | -384.55 | -377.53 |
D&A For EBITDA | 35.67 | 34.64 | 35.91 | 33.68 | 27.78 | 21.34 |
EBIT | -268.47 | -273 | -289.12 | -453.84 | -412.34 | -398.87 |